NEW
YORK, July 30, 2024 /PRNewswire/ -- The global
gel documentation systems market size is estimated to grow by
USD 52.21 million from 2023-2027,
according to Technavio. The market is estimated to grow at a CAGR
of about 3.58% during the forecast period. Increase in use of
molecular biology techniques in clinical practice is driving market
growth, with a trend towards rising costs of clinical trials.
However, lack of efficiency and effectiveness compared to
conventional methods poses a challenge. Key market players
include ATTO Corporation, Azure Biosystems Inc., Bio Rad
Laboratories Inc., Bio Techne Corp., Carestream Health Inc, Cleaver
Scientific Ltd., Clinx Science Instruments Co. Ltd., Corning Inc.,
Endress Hauser Group Services AG, Gel Co. Inc, General Electric
Co., GOLD SIM International Group Co. Ltd., Isogen Life Science BV,
LI COR Inc., Royal Bio Tech, SDI Group plc, Thermo Fisher
Scientific Inc., Vilber Lourmat, VWR International LLC, and Wealtec
Corp..
![Technavio has announced its latest market research report titled Global Gel Documentation Systems Market 2023-2027 Technavio has announced its latest market research report titled Global Gel Documentation Systems Market 2023-2027](https://mma.prnewswire.com/media/2470790/20221230075313_bw_info_v4.jpg)
Get a detailed analysis on regions, market
segments, customer landscape, and companies- View the
snapshot of this report
Gel Documentation
Systems Market Scope
|
Report
Coverage
|
Details
|
Base year
|
2022
|
Historic
period
|
2017 - 2021
|
Forecast
period
|
2023-2027
|
Growth momentum &
CAGR
|
Accelerate at a CAGR of
3.58%
|
Market growth
2023-2027
|
USD 52.21
million
|
Market
structure
|
Fragmented
|
YoY growth 2022-2023
(%)
|
2.5
|
Regional
analysis
|
North America, Europe,
Asia, and Rest of World (ROW)
|
Performing market
contribution
|
North America at
37%
|
Key
countries
|
US, Canada, UK,
Germany, and China
|
Key companies
profiled
|
ATTO Corporation, Azure
Biosystems Inc., Bio Rad Laboratories Inc., Bio Techne Corp.,
Carestream Health Inc, Cleaver Scientific Ltd., Clinx Science
Instruments Co. Ltd., Corning Inc., Endress Hauser Group Services
AG, Gel Co. Inc, General Electric Co., GOLD SIM International Group
Co. Ltd., Isogen Life Science BV, LI COR Inc., Royal Bio Tech, SDI
Group plc, Thermo Fisher Scientific Inc., Vilber Lourmat, VWR
International LLC, and Wealtec Corp.
|
Market Driver
The clinical trials process for bringing new drugs to market is
a complex and costly endeavor for pharmaceutical companies. With
increasing regulations requiring more clinical data and longer
safety testing periods, clinical trials for chronic disease
treatments can be particularly expensive, often costing between
USD300-350 million per drug from the
clinical stage to commercialization. However, with multiple
projects in development, the overall cost can reach USD3-5 billion. One of the major challenges in
clinical trials is patient recruitment and retention, with
approximately 45-50% of trials in the US delayed due to these
issues. To address this, companies must focus on patient education
and awareness, rather than persuasion, to encourage willing
participation. This patient-centric approach could help resolve
recruitment and continuation issues, leading to a more efficient
clinical trials process. As the clinical research industry
continues to grow, the need for analytical instruments like gel
documentation systems will also increase, making them a valuable
investment for clinical research labs, hospitals, and diagnostic
centers.
Gel documentation systems have gained significant traction in
various industries, including hospitals, diagnostic laboratories,
pharmaceutical and biotechnology corporations. These systems are
essential for imaging and recording results from agarose and
acrylamide gels used in molecular biology. They find extensive
applications in nucleic acid and protein research, with
technologies like ethidium bromide, fluorophores (SYBR Green),
protein quantification, immunoassays, 2D electrophoresis, and
nucleic acid quantification. Gel documentation systems are crucial
in identifying infectious diseases and genetic disorders. They
employ digital systems, ultraviolet, chemiluminescence, and
fluorescence techniques for imaging. Accessories and software
enhance their functionality, while computer vision techniques
enable biomedical movies and microscopy. Neutrophils immune cells,
cardiovascular disease, cancer research, and treatment of diseases
are some areas benefiting from these advanced systems. Gel
documentation systems contribute significantly to molecular
biology, enabling precise analysis of DNA, RNA, and
proteins.
Discover 360° analysis of this market. For
complete information, schedule your consultation - Book
Here!
Market Challenges
- Molecular diagnostics, while offering advantages, cannot fully
replace conventional diagnostic methods for infectious diseases due
to the efficiency and affordability of current clinical
microbiology techniques. Rapid antigen tests and automated culture
systems have advanced, enabling quicker identification and
susceptibility testing. However, limitations exist with molecular
techniques, such as false positives and negatives. To mitigate
these issues, specialized laboratories with trained staff and
adequate space are necessary. Improper primer design and
contaminants inhibiting enzyme activity can also lead to inaccurate
results. Negative controls, such as ultraviolet light irradiation
and chemical inactivation, are essential to prevent incorrect
outcomes. Despite advancements, inexpensive and simple microarray
technologies are not yet available to address the issue of
detecting organisms with unknown sequences.
- Gel documentation systems are essential tools in various
industries, particularly in molecular biology labs, for analyzing
nucleic acids and proteins. These systems facilitate the
visualization and documentation of gel images, which are crucial in
fields like nucleic acid quantification, infectious diseases, and
genetic disorders. Challenges in this market include the need for
accurate quantification of nucleic acids, identification of
infectious diseases, and detection of genetic disorders.
Accessories, software, and techniques like ultraviolet,
chemiluminescence, and fluorescence are used to address these
challenges. Gel documentation systems support various types of
gels, including Agarose and Acrylamide, and employ digital systems
for improved gel imaging. They are used in molecular biology for
DNA separation, sequencing, preparation, and labeling. Technologies
like computer vision techniques, biomedical movies, and microscopy
aid in the analysis of cells, such as neutrophils immune cells, and
the study of cardiovascular disease. All-in-one gel documentation
systems cater to the needs of researchers and diagnostics,
providing advanced features for handling various gel types and
analysis techniques. These systems are integral to the treatment of
diseases like cancer, and the development of sequencing
technologies.
For more insights on driver and
challenges - Request a sample report!
Segment Overview
This gel documentation systems market report extensively covers
market segmentation by
- Product
- 1.1 Instruments
- 1.2 Software
- 1.3 Accessories
- End-user
- 2.1 Hospitals and diagnostic centers
- 2.2 Pharma and biotech companies
- 2.3 Academic and research institutes
- Geography
- 3.1 North America
- 3.2 Europe
- 3.3 Asia
- 3.4 Rest of World (ROW)
1.1 Instruments- The Gel Documentation Systems
market refers to the industry that provides solutions for creating,
managing, and publishing technical documentation. These systems
help businesses streamline their documentation process, ensuring
accurate and up-to-date information for their customers and
internal teams. Features include version control, easy authoring,
and integration with other business tools. Companies benefit from
improved efficiency, reduced errors, and enhanced customer
support.
For more information on market segmentation with geographical
analysis including forecast (2023-2027) and historic data
(2017-2021) - Download a Sample Report
Research Analysis
Gel documentation systems are advanced instruments used in
various fields of life sciences, including molecular biology,
hospitals, diagnostic laboratories, pharmaceutical corporations,
and biotechnology corporations. These systems enable the imaging
and recording of gels, such as agarose and acrylamide gels, used in
the analysis of nucleic acids, proteins, and other biological
materials. Imaging and recording are accomplished using techniques
like ethidium bromide staining, fluorophores such as SYBR Green,
and computer vision techniques. Biomedical movies and microscopy
are often employed to observe cells and immune cells, such as
neutrophils, in real-time. Gel documentation systems are essential
tools for protein quantification and the analysis of cardiovascular
disease, among other applications. They offer digital systems that
enhance the accuracy and efficiency of gel imaging, making them
indispensable in modern laboratories. Gel documentation systems are
used extensively in molecular biology research, particularly in the
analysis of nucleic acids and proteins. These systems facilitate
the visualization and quantification of biomolecules, enabling
researchers to gain valuable insights into biological processes and
develop new therapeutics.
Market Research Overview
Gel documentation systems are advanced instruments used for
imaging and recording results from various gel-based experiments in
the fields of molecular biology, diagnostics, and research. These
systems are employed in hospitals, diagnostic laboratories,
pharmaceutical corporations, and biotechnology corporations for the
analysis of nucleic acids, proteins, and other biomolecules.
Agarose gels, acrylamide gels, and other types of gels are used in
these systems for separation, sequencing, preparation, and labeling
of nucleic acids. Ethidium bromide, fluorophores such as SYBR
Green, and other staining methods are used for visualization. Gel
documentation systems utilize digital systems, computer vision
techniques, ultraviolet, chemiluminescence, and fluorescence for
imaging and analysis. Applications include nucleic acid and protein
quantification, immunoassays, 2D electrophoresis, infectious
diseases, genetic disorders, and cancer research. Accessories and
software are also available for these systems, along with
microscopy, biomedical movies, and cell analysis. Gel image systems
and gel imagers are essential tools in molecular biology labs for
the treatment of diseases and advancements in sequencing
technologies. Deoxyribonucleic acid (DNA) and other nucleic acids
are prepared and separated using these systems, with labeling and
staining methods such as Coomassie Brilliant Blue, silver staining,
and all-in-one systems. Cellulose, agarose, acrylamide, and other
materials are used in the preparation of gels. Gel documentation
systems are integral to the advancement of research and diagnostics
in various fields.
Table of Contents:
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation
- Product
-
- Instruments
- Software
- Accessories
- End-user
-
- Hospitals And Diagnostic Centers
- Pharma And Biotech Companies
- Academic And Research Institutes
- Geography
-
- North America
- Europe
- Asia
- Rest Of World (ROW)
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix
About Technavio
Technavio is a leading global technology research and advisory
company. Their research and analysis focuses on emerging market
trends and provides actionable insights to help businesses identify
market opportunities and develop effective strategies to optimize
their market positions.
With over 500 specialized analysts, Technavio's report library
consists of more than 17,000 reports and counting, covering 800
technologies, spanning across 50 countries. Their client base
consists of enterprises of all sizes, including more than 100
Fortune 500 companies. This growing client base relies on
Technavio's comprehensive coverage, extensive research, and
actionable market insights to identify opportunities in existing
and potential markets and assess their competitive positions within
changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
View original content to download
multimedia:https://www.prnewswire.com/news-releases/gel-documentation-systems-market-size-is-set-to-grow-by-usd-52-21-million-from-2023-2027--increase-in-use-of-molecular-biology-techniques-in-clinical-practice-boost-the-market-technavio-302209595.html
SOURCE Technavio